The reduction, KFF found, is likely reflecting recent state budget challenges and the significant costs associated with coverage. Medicaid cuts within President Donald Trumps omnibus tax and spending bill could further exacerbate existing cost concerns, KFFs survey found (On the federal side, the Trump administration has sent mixed signals on GLP-1s, walking back a planned public coverage expansion in the spring but cutting a deal with drugmakers to expand Medicare access in the fall.) Still, the cost pressure of these drugs is acute in Pennsylvania, where lawmakers needed 135 extra days to cut a budget deal in part due to the states increasingly tough financial picture
We've found that this on-label versus off-label distinction is the single biggest barrier patients face
This article will detail the various uses of Semaglutide, how it works, its common side effects, and who it may be suitable for
PlexusDx can help coordinate your restart timing and may adjust your dosage plan based on your recovery progress
Bioavailability is still low, but it is useful for long-term management as this form is over-the-counter